BD Institute for Medication Management Excellence

Helping to advance the safe and efficient management of medications across the care continuum

The BD Institute for Medication Management Excellence works with customers and industry thought leaders to transform medication management in meaningful ways and engages others to join the effort. The goal is to identify and support evolutionary―and revolutionary―advancements by encouraging new ways of thinking, new methods, processes, guidelines and best practices to create a foundation for measurable improvements.

The institute strives to consistently deliver high impact thought leadership initiatives. It also works to engage with health systems, clinicians, technology partners, regulatory organizations and thought leaders to create a forum for insightful research and best practices to directly impact patient safety.


Key initiatives include:

1

Opioid control and management
Addressing clinical and operational medication management and drug diversion issues to define solutions for the rising opioid epidemic in acute care.

Learn more

2

End to end medication safety
Improving medication safety from initial compounding all the way to administration at the bedside.

Learn more

3

Inventory optimization
Ensuring the right medication is available when and where needed to improve patient outcomes and cost efficiencies across the continuum of care.

Learn more


Firstname Lastname

Job Tile Number One,
Job Title Number Two

Firstname Lastname

Job Tile Number One,
Job Title Number Two

Educational resources

Join us for a webinar series on managing opioids in the acute care setting
Abuse of prescription opioids has grown dramatically over the last 15 years,1 becoming one of the most serious public health problems in the United States. Opioids are overprescribed, resulting in nonmedical consumption and abuse, and often leading to the use of illicit forms of opiates such as heroin. The prescription opioid crisis costs our country an estimated $55 billion in health and social costs every year2 with devastating consequences to communities and families across the country. Acute care providers are on the front lines of this public health epidemic every day as a result of drug diversion, transitions of care from the hospital and the toll on emergency departments. 

In this series, we will discuss the advantages of a collaborative approach to managing controlled substances, and learn about the value of a culture of safety as part of a health system's drug diversion deterrence plan.

The role of the medication safety officer in addressing institutional drug diversion
The Medication Safety Officer is a new and important role in health systems. Learn how creating a culture of safety can help to deter diversion of controlled substances. 
Recorded: May 18, 2018 
Speaker: Christina Michalek, BSc Pharm, RPh, FASHP, Medication Safety Specialist, Institute for Safe Medication Practices
Watch now

This activity, for one contact hour, is provided by BD Medical Clinical Resource Services Department, which is accredited as a provider of continuing education by the California Board of Registered Nursing, provider #CEP 13136. This certificate must be retained by the attendee for a period of four years. 

Decreasing the risk of drug diversion: a nursing viewpoint, a collaborative approach
Drug diversion is not a nursing problem. Drug diversion is not a pharmacy problem. Drug diversion is a systemic problem and the risks are better managed with a collaborative approach.
Date: July 20, 2018
Time: 9-10 a.m. (PST)
Speaker: Kimberly New, JD, BSN, RN, Executive Director, International Health Facility Diversion Association
Register now

This activity, for one contact hour, is provided by BD Medical Clinical Resource Services Department, which is accredited as a provider of continuing education by the California Board of Registered Nursing, provider #CEP 13136. This certificate must be retained by the attendee for a period of four years. 

Recorded webinars
SeriesProgramSpeakerRecording
Managing IV therapies Finding and Addressing the Gaps in the IV Medication Management Process* (1 nursing contact hour) Michelle Mandrack, MSN, RN, Director of Consulting Services, ISMP Watch Now
Managing IV therapies Use of Automated Technology to Improve IV Room Operations and Reduce Medication Errors Ruth E. Cassidy, B.S. PharmD, FACHE, SVP Clinical Support Services, Chief Pharmacy Officer, SBH Health System Watch Now
Managing IV therapies Peripheral IVs: Infection Risks, Evidence and Patient Satisfaction Michelle DeVries, MPH CIC, Senior Infection Control Officer, Methodist Hospitals Watch Now
Managing IV therapies Mitigating Risk of Extravasation with Power Injection Lynn Hadaway, M.Ed., RN-BC, CRNI, Founder, Infusion Nursing Society (INS) Watch Now
Managing IV therapies Clinical Evidence and Product Performance: Finding the Sweet Spot for Innovation and Improved Outcomes Ruth Carrico, PhD, MSN, APRN, FNP-C, FSHEA, CIC Watch Now
Enterprise medication management Enterprise Medication Management: The Basics Gina Lohr, MPP, Senior Consultant, The Advisory Board Watch Now
Enterprise medication management Enterprise Medication Strategy: Shared Services, Shared Objectives for the Front Line Bonnie Levin, Pharm D, MBA, AVP, Pharmacy Services, MedStar Health Watch Now
Managing opioids The role of the medication safety officer in addressing institutional drug diversion* (1 nursing contact hour) Christina Michalek, BSc Pharm, RPh, FASHP, Medication Safety Specialist, ISMP Watch Now
Managing opioids Drug Diversion in Healthcare Facilities: a Law Enforcement Perspective John Burke, President, International Health Facility Diversion Association Watch Now
Managing opioids Opioid Crisis, Healthcare Systems and Drug Diversion: Legal Mandates and Patient Safety Imperatives Chris Fortier, PharmD, Chief Pharmacy Officer, Massachusetts General Hospital Watch Now
Managing opioids Practical Applications to Manage Controlled Substances in Acute Care Settings Robert Fink, PharmD, MBA, FACHE, FASHP, BCNSP, BCPS, VP Ancillary Services and Chief Pharmacy Executive, Quorum Health Watch Now
Managing opioids Reflections From an Early Adopter of Continuous Capnography Monitoring for Opioid Administration Harold Oglesby, RRT, Manager of Center for Pulmonary Health, St. Joseph's/Candler Watch Now
ISMP Planning for a Seamless Transition for Infusion Pump Integration with the EHR* (Nursing and Pharmacy CE credit) Sondra May, PharmD, Medication Safety Coordinator, University of Colorado Hospital; Joanna Caranante, PharmD, BCPS, Pharmacy Clinical Director and Residency Program Director, St. Joseph's Hospital Watch Now
ISMP Changing the Safety Paradigm on IV Medication Use: Recognizing the Risk and Taking Action* (1 nursing contact hour) Susan Paparella, MSN, RN, VP, ISMP; Michelle Mandrack, MSN, RN, Director of Consulting Services, ISMP Watch Now

References
  1. Rudd RA, Noah A, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014. CDC MMWR. 2016; 64(50);1378-82.
  2. Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12(4):657-67.